Investor Presentaiton
Top-tier talent
Differentiated process
Scalable platform
Growing our team for the significant opportunity ahead
Research & Investments team (1)
6
>3x
13
21
2012
2020
2021
2025e
Investment
reviews
~50
>265 >300
Growth
Deep experience in Research & Investments (1)
21 professionals
~5 year average tenure at Royalty Pharma (2)
~14
year average biopharma and/or investment
experience (2)
>60% advanced degrees
~50% scientific and/or medical degrees(3)
1. Includes Research & Investments, Investments & Capital Strategies and Strategy & Analytics.
ROYALTY PHARMA
2.
Average tenure and average biopharma and/or investment experience is among senior leadership (VPs and above) at Royalty Pharma.
3.
Includes Doctor of Philosophy (PhD) in scientific fields and/or Doctor of Medicine (MD).
51View entire presentation